Lv21
180 积分 2026-01-13 加入
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial
2小时前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
2小时前
已完结
Adjuvant Nivolumab vs Observation in Resected Non–Small Cell Lung Cancer
2小时前
求助中
LRP1调控Aβ代谢的机制及其对AD防治研究的启示
22天前
已完结
Systemic and Local Delivery of siRNA to the CNS and Periphery via Anti-IGF1R Antibody Conjugation
27天前
已关闭
关于司美格鲁肽生物类似药质量相似性评价的思考
29天前
已完结
五加皮酒治疗风湿性关节炎的研究进展
1个月前
已关闭
Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
3个月前
已完结
龄相关性黄斑变性的新概念:定义与发病机制
4个月前
已完结
Brain Distribution of Drugs: Pharmacokinetic Considerations
4个月前
已完结
皖公网安备34019202002308
